Converting to molar terms uses the compound's molecular weight (the palmitoyl group adds roughly 238 Da over the free tripeptide, so the lipidated molecule is heavier than GHK always calculate from the exact MW on the certificate of analysis for the specific lot)
Results vary, and no program can guarantee a specific outcome
And I think that thats really important because if you do get an immobilizer and you have your leg immobilized, if youre going to come back from that, we need to know that if you have the GLP-1s, does it prevent you from increasing your muscle mass and strength again in the rehab period of time

Seek urgent medical attention (A&E or call 999) if experiencing: Severe, persistent abdominal pain that is constant or worsening, particularly if localised to the upper abdomen or radiating to the back (potential pancreatitis) Persistent vomiting preventing oral fluid intake for more than 24 hours (risk of dehydration and acute kidney injury) Signs of dehydration including reduced urine output, dizziness, confusion, or rapid heartbeat Blood in vomit or stools (haematemesis or melaena) Severe allergic reactions such as facial swelling, difficulty breathing, or widespread rash Contact your GP or diabetes specialist nurse within 2448 hours for: Diarrhoea persisting beyond one week or more than 68 loose stools daily Unintentional weight loss exceeding 12 kg per week Symptoms significantly impacting daily activities or quality of life New or worsening abdominal pain that is moderate in severity Persistent nausea preventing adequate nutritional intake Symptoms of gallbladder disease including right upper quadrant pain, particularly after fatty meals Worsening vision or eye symptoms , particularly in patients with pre-existing diabetic retinopathy Routine review is appropriate for: Mild, manageable symptoms that are improving with dietary modifications Questions about symptom management strategies Discussion of dose adjustment if symptoms are troublesome but not severe If unsure about the urgency of symptoms, contact NHS 111 for advice

These shortage resolutions matter because FDA guidance on compounding indicates that compounded drugs may be appropriate when a patient's medical need cannot be met by an FDA-approved drug, or when the approved drug is not commercially available